Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven D Schwartz

Showing results (161-170 of 184) with videos related to

Pageof 19
Sort By:
Ophthalmology|July 7, 2009
Endophthalmitis after pars plana vitrectomy a 20- and 25-gauge comparisonAllen Y H Hu, Jean-Louis Bourges, Sumit P Shah, et al.
Vision (Basel, Switzerland)|November 20, 2019
Comparison of Outcomes between Endoscopic and Transcleral CyclophotocoagulationRobert Beardsley, Simon K Law, Joseph Caprioli, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|November 27, 2020
Clinical characteristics and visual outcomes of non-resolving subretinal fluid in neovascular AMD despite continuous monthly anti-VEGF injections: a long-term follow-upHamid Hosseini, Gilad Rabina, Moritz Pettenkofer, et al.
Biochemistry|June 13, 2017
Clinically Divergent Mutation Effects on the Structure and Function of the Human Cardiac Tropomyosin OverlapMark McConnell, Lauren Tal Grinspan, Michael R Williams, et al.
Retina (Philadelphia, Pa.)|October 21, 2021
PIGMENT EPITHELIAL DETACHMENT IN AGE-RELATED MACULAR DEGENERATION: Long-Term Visual Acuity May Improve With Higher Injection IndexWei Gui, Adrian Au, Gilad Rabina, et al.
Ophthalmology|May 12, 2005
Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degenerationPhilip J Rosenfeld, Steven D Schwartz, Mark S Blumenkranz, et al.
Retina (Philadelphia, Pa.)|December 26, 2021
RETINAL DETACHMENT IN EYES WITH BOSTON TYPE 1 KERATOPROSTHESIS: Surgical Techniques and Mid-Term OutcomesClémence Bonnet, Ismael Chehaibou, Colin A McCannel, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2005
Changes in the chemical and dynamic properties of cardiac troponin T cause discrete cardiomyopathies in transgenic miceBriar R Ertz-Berger, Huamei He, Candice Dowell, et al.
Lancet (London, England)|January 28, 2012
Embryonic stem cell trials for macular degeneration: a preliminary reportSteven D Schwartz, Jean-Pierre Hubschman, Gad Heilwell, et al.
American Journal of Ophthalmology|December 23, 2014
Ciliary neurotrophic factor for macular telangiectasia type 2: results from a phase 1 safety trialEmily Y Chew, Traci E Clemons, Tunde Peto, et al.
Pageof 19

Showing results (161-170 of 184) with videos related to

Sort By:
Pageof 19
Ophthalmology|July 7, 2009
Endophthalmitis after pars plana vitrectomy a 20- and 25-gauge comparisonAllen Y H Hu, Jean-Louis Bourges, Sumit P Shah, et al.
Vision (Basel, Switzerland)|November 20, 2019
Comparison of Outcomes between Endoscopic and Transcleral CyclophotocoagulationRobert Beardsley, Simon K Law, Joseph Caprioli, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|November 27, 2020
Clinical characteristics and visual outcomes of non-resolving subretinal fluid in neovascular AMD despite continuous monthly anti-VEGF injections: a long-term follow-upHamid Hosseini, Gilad Rabina, Moritz Pettenkofer, et al.
Biochemistry|June 13, 2017
Clinically Divergent Mutation Effects on the Structure and Function of the Human Cardiac Tropomyosin OverlapMark McConnell, Lauren Tal Grinspan, Michael R Williams, et al.
Retina (Philadelphia, Pa.)|October 21, 2021
PIGMENT EPITHELIAL DETACHMENT IN AGE-RELATED MACULAR DEGENERATION: Long-Term Visual Acuity May Improve With Higher Injection IndexWei Gui, Adrian Au, Gilad Rabina, et al.
Ophthalmology|May 12, 2005
Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degenerationPhilip J Rosenfeld, Steven D Schwartz, Mark S Blumenkranz, et al.
Retina (Philadelphia, Pa.)|December 26, 2021
RETINAL DETACHMENT IN EYES WITH BOSTON TYPE 1 KERATOPROSTHESIS: Surgical Techniques and Mid-Term OutcomesClémence Bonnet, Ismael Chehaibou, Colin A McCannel, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 6, 2005
Changes in the chemical and dynamic properties of cardiac troponin T cause discrete cardiomyopathies in transgenic miceBriar R Ertz-Berger, Huamei He, Candice Dowell, et al.
Lancet (London, England)|January 28, 2012
Embryonic stem cell trials for macular degeneration: a preliminary reportSteven D Schwartz, Jean-Pierre Hubschman, Gad Heilwell, et al.
American Journal of Ophthalmology|December 23, 2014
Ciliary neurotrophic factor for macular telangiectasia type 2: results from a phase 1 safety trialEmily Y Chew, Traci E Clemons, Tunde Peto, et al.
Pageof 19